AI 주식은 비쌉니다. 현재 $12짜리 주식이 가장 저렴한 투자처일까요?
작성자 Maksym Misichenko · Yahoo Finance ·
작성자 Maksym Misichenko · Yahoo Finance ·
AI 에이전트가 이 뉴스에 대해 생각하는 것
UiPath's transition to GAAP profitability and high net retention is impressive, but decelerating ARR growth and competitive pressure from hyperscalers like Microsoft pose significant risks. The company's ability to defend its moat and maintain new logo growth will be crucial.
리스크: Competitive pressure from Microsoft and other hyperscalers embedding automation into their existing stacks, and the potential lengthening of automation ROI cycles as enterprises exhaust low-hanging fruit.
기회: UiPath's high net retention rate and the potential for steady enterprise adoption of AI as it scales automation.
이 분석은 StockScreener 파이프라인에서 생성됩니다 — 4개의 주요 LLM(Claude, GPT, Gemini, Grok)이 동일한 프롬프트를 받으며 내장된 환각 방지 가드가 있습니다. 방법론 읽기 →
인공지능(AI) 주식은 최근 몇 년간 급등했지만, 현재 많은 주식이 비싸 보입니다. 평가 가치가 상승함에 따라 투자자들은 프리미엄 가격표 없이도 성장 잠재력을 여전히 제공하는 간과된 기회를 찾고 있습니다. 주목할 만한 기업 중 하나는 UiPath (PATH)입니다. 이 주식은 현재 $12에 거래되고 있으며, 연초 이후(YTD) 26% 하락하고 최근 최고가인 $19.84보다 39% 낮은 수준입니다.
급격한 하락에도 불구하고 2026 회계년도 4분기 수익은 주가보다 사업이 더 강력할 수 있음을 시사합니다.
Barchart의 더 많은 뉴스
이 저평가된 AI 주식이 다시 한번 주목받을 만한 이유를 알아봅시다.
UiPath: 다른 종류의 AI 투자
UiPath는 화려한 AI 스토리가 아닙니다. 대신 복잡한 비즈니스 프로세스 전체에서 자동화를 관리, 관리 및 확장하도록 설계된 플랫폼을 구축하고 있습니다. AI가 소프트웨어 개발 비용을 낮춤에 따라 안정적으로 실행하고 확장할 수 있는 플랫폼의 가치가 이동할 수 있습니다. UiPath는 이러한 요구를 충족하기 위해 노력하고 있습니다. 이것이 즉각적인 관심을 불러일으키지는 않겠지만 시간이 지남에 따라 더 오래 지속될 수 있습니다.
2026 회계년도 4분기에 UiPath는 총 매출 4억 8100만 달러, 전년 동기(YoY) 대비 14% 증가, 연간 반복 수익(ARR) 18억 5300만 달러로 11% 증가를 보고했습니다. 주목할 만한 점은 $100만 이상의 ARR을 창출하는 고객의 90%가 이미 UiPath의 AI 제품을 사용하고 있다는 것입니다. 순유지율은 107%로 꾸준히 유지되어 고객이 사용량을 꾸준히 늘리고 있음을 보여줍니다. 이 회사의 가장 큰 성과는 2026 회계연도에 전체 GAAP 수익성을 달성한 것입니다. 순이익은 2025 회계연도 손실 $0.13 주당 대비 주당 $0.52였습니다. UiPath는 고성장, 손실 기업에서 성장과 수익성의 균형 잡힌 모델로 진화했습니다. 총 마진은 86%, 소프트웨어 마진은 92%로 여전히 견조했습니다.
경영진은 AI가 기존 자동화 제품을 대체하는 것이 아니라고 강조했습니다. 대신 AI는 이를 확장하고 개선하여 점점 더 복잡한 워크플로에서 자동화할 수 있는 기회를 더 많이 제공합니다. UiPath는 2027 회계년도에 20억 달러 이상의 ARR을 예상하며, 순 신규 ARR은 약 2억 달러입니다. 이는 지속적, 즉 폭발적인 성장을 보여줍니다.
4개 주요 AI 모델이 이 기사를 논의합니다
"PATH is operationally improving but valuation is fairly priced for mid-teens growth, not a bargain, and faces structural headwinds from AI commoditization that the article ignores."
UiPath's transition to GAAP profitability ($0.52 EPS) and 107% net retention are genuine operational improvements, but the article conflates 'cheaper than peers' with 'cheap.' At $12, PATH trades ~23x forward P/E on $2B+ ARR guidance—not a screaming bargain for 11-14% growth. The real risk: automation ROI cycles are lengthening as enterprises exhaust low-hanging fruit. The 90% AI product adoption claim is encouraging but unverified; if it's mostly add-on revenue rather than net-new deals, the $200M net new ARR target looks soft. The article ignores competitive pressure from Microsoft (MSFT) embedding automation into Copilot and from pure-play RPA consolidation.
PATH's 14% revenue growth and guidance for $2B ARR masks that growth is decelerating (ARR +11% vs. prior-year trends), and at 23x forward P/E it's not materially cheaper than SaaS peers—just cheaper than Nvidia. The profitability inflection could be one-time margin engineering rather than durable.
"UiPath’s transition to GAAP profitability is a necessary survival step, but its decelerating ARR growth suggests it is losing the battle for enterprise mindshare to integrated platform incumbents."
UiPath (PATH) is transitioning from a high-burn growth story to a disciplined operator, yet the market is punishing it for decelerating ARR growth. While 14% revenue growth and GAAP profitability are impressive, the sub-12% ARR growth target for FY2027 signals a company maturing into a utility rather than a hyper-growth AI disruptor. At $12, the valuation reflects skepticism regarding its ability to defend its moat against hyperscalers like Microsoft or ServiceNow, which are aggressively embedding automation into their existing stacks. Investors are essentially betting that UiPath’s specialized 'agentic' workflow governance remains stickier than the native tools provided by the platforms where the data already lives.
The bear case is that UiPath is a 'feature, not a product' that will be cannibalized by LLM-native agents, rendering their specialized automation platform redundant as AI models gain the ability to navigate UIs autonomously.
"UiPath's strong margins and GAAP profitability make it a reasonable way to access enterprise automation, but the stock will only rerate if ARR growth sustainably reaccelerates and it preserves differentiation versus big‑tech and low‑cost rivals."
UiPath (PATH) looks materially cheaper than the frothy 'AI' darlings and the Q4/fiscal‑2026 results show a healthy enterprise franchise: ARR $1.853B (+11% YoY), revenue $481M (+14%), 107% net retention, and full‑year GAAP profitability with very high gross/software margins. That said, the underlying growth rate is modest for a software growth stock and guidance (net new ARR ~ $200M to push ARR > $2B) implies only ~10–11% ARR growth — not a re‑acceleration. Key watchpoints: sustainability of GAAP profits (one‑offs or durable operational leverage), customer concentration/renewal trends, and whether UiPath can defend against big‑tech bundles and lower‑cost RPA competitors as AI tooling commoditizes.
This could be a value trap: if ARR growth stalls further and large cloud or automation vendors bundle comparable capabilities, PATH could suffer multiple compression despite strong margins. Profitability might be driven by cost cuts rather than durable revenue strength, masking weaker product demand.
"PATH's profitability milestone and AI-integrated platform enable durable mid-teens growth at a discounted $12 price, undervalued relative to pure AI plays."
UiPath's Q4 FY2026 results mark a key inflection—GAAP profitability ($0.52/share vs. prior loss), 14% revenue growth to $481M, 11% ARR to $1.853B, and 107% net retention—validating its shift from hypergrowth to sustainable model in RPA. With 90% of $1M+ ARR clients on AI products and FY2027 ARR guidance >$2B (implying ~$200M net new), it's positioned for steady enterprise adoption as AI scales automation. At $12 (down 26% YTD), it offers AI exposure without frothy multiples, but decelerating growth from prior years tempers re-rating potential amid fierce competition.
Enterprise software budgets face macro headwinds from slowing IT spend and recession fears, potentially stalling net new ARR below $200M; meanwhile, giants like Microsoft Power Automate could commoditize RPA, eroding PATH's differentiation.
"The Microsoft cannibalization risk is real but underdimensioned—the real tell is whether PATH loses net-new ARR to Power Automate, not whether existing customers churn."
Nobody's quantified the Microsoft Power Automate threat credibly. OpenAI flags it as risk; Anthropic mentions it; but we're missing specifics. Power Automate's embedded-in-Office advantage is real, yet PATH's 107% NRR suggests customers aren't churning to it. The gap: does PATH lose *new* logos to MSFT while retaining existing ones? That's the actual margin compression vector, not just multiple re-rating. Need Q1 guidance revision to settle this.
"UiPath's reliance on UI-based automation faces obsolescence as enterprises shift toward direct API-based agentic workflows."
Anthropic and Grok are missing the 'agentic' shift. UiPath’s 107% NRR isn't a moat; it’s a symptom of vendor lock-in during the transition from legacy RPA to LLM-orchestration. The real risk isn't just Microsoft bundling—it's the 'API-first' trend. As enterprises move toward direct LLM-to-API integrations, UiPath’s UI-scraping 'robot' layer becomes a technical debt burden rather than an asset. If net-new logos stall, that NRR will collapse as customers migrate workflows to native cloud-native agent frameworks.
"The 'API-first' threat is overstated because legacy, API-poor enterprise systems create a durable runway for UiPath's UI automation."
Google's 'API-first' doom loop understates enterprise reality: many Fortune 500 workflows run on legacy, API-poor apps (SAP custom screens, proprietary ERPs) where UI automation is the only practical path today. Migrating critical processes to API-native agents is multi-year, high-cost work, so UiPath retains a durable beachhead and time to morph into an orchestration layer or partner with hyperscalers. Key monitor: new-logo win rate versus IT modernization cadence.
"UiPath's AI adoption drives NRR via expansions, not new logos, risking FY27 net new ARR target."
Google's API-first shift ignores UiPath's explicit pivot: 90% of $1M+ ARR customers use their agentic AI suite (Autopilot/Agent Builder), blending UI scraping with LLM orchestration for legacy gaps OpenAI flags. But flaw: this NRR boost is 80% expansion-only per Q4 details—no new-logo acceleration. Anthropic's point stands; $200M net new ARR needs proof in Q1, else deceleration worsens.
UiPath's transition to GAAP profitability and high net retention is impressive, but decelerating ARR growth and competitive pressure from hyperscalers like Microsoft pose significant risks. The company's ability to defend its moat and maintain new logo growth will be crucial.
UiPath's high net retention rate and the potential for steady enterprise adoption of AI as it scales automation.
Competitive pressure from Microsoft and other hyperscalers embedding automation into their existing stacks, and the potential lengthening of automation ROI cycles as enterprises exhaust low-hanging fruit.